To qualify for treatment, a patient needs to have a body-mass index of 27 or higher with a metabolic-health problem like high cholesterol or hypertension, or a BMI of 30 with no associated metabolic-health problems
Each order includes 1 dosing pen containing 30 mg Retatrutide (300 clicks) plus 12 attachment needles
Furthermore, CGM and GLP-1 use has led to clinically significant A1C reductions, which is huge for long-term health
Sources: Tirzepatide Once Weekly for the Treatment of Obesity | New England Journal of Medicine Realworld use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity database PMC Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity | Obesity | JAMA Internal Medicine | JAMA Network Semaglutide StatPearls NCBI Bookshelf Safety of Semaglutide PMC Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes PMC Realworld evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP1RAbased weightloss therapies PMC Liraglutide for weight management: a critical review of the evidence PMC Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus PMC Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial | Clinical Pharmacy and Pharmacology | JAMA | JAMA Network
Tracking biomarkers across these systems enables better care 85%+ Muscle mass preserved With guidance, patients preserve lean muscle through targeted protein and strength protocols Most GLP-1 programs fall short Without clinical support Higher risk of losing lean tissue Muscle loss Derail treatment adherence Side effects Weight loss without metabolic health No metabolic tracking Most quit within 6 months Early discontinuation Multi-system intervention Success measured across the body Clinician-led care with ongoing oversight Dosing, tolerance, and response actively managed Decisions guided by biological feedback Biomarkers and symptoms used to protect long-term health Long-term healthspan Designed to support aging, resilience, and metabolic health Clinician-guided GLP-1 treatment Your clinician reviews your medical history and goals to determine eligibility and guide the right treatment choice, including injectable or oral options
